|
Patterns of comorbidity, treatment, resource utilization, and referral in malignant pleural mesothelioma patients in the US. |
|
|
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Genentech/Roche; Imedex; Lilly; MedImmune; Novartis |
Research Funding - Genentech/Roche (Inst); MedImmune (Inst); Merck (Inst); Millennium; Seagen |
Travel, Accommodations, Expenses - Novartis |
|
|
No Relationships to Disclose |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Allergan; Roche |
Research Funding - Genentech/Roche |
|
|
|
|
Travel, Accommodations, Expenses - Roche |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
Honoraria - Bristol-Myers Squibb; Roche |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb |
Speakers' Bureau - Pierre Fabre; Roche |